Viewing StudyNCT02254551



Ignite Creation Date: 2024-05-06 @ 3:17 AM
Last Modification Date: 2024-10-26 @ 11:31 AM
Study NCT ID: NCT02254551
Status: TERMINATED
Last Update Posted: 2017-02-16
First Post: 2014-09-29

Brief Title: SafetyEfficacy Study of LDE225 Sonidegib Plus Bortezomib in Patients With Relapsed or RelapsedRefractory Multiple Myeloma
Sponsor: SCRI Development Innovations LLC
Organization: SCRI Development Innovations LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-01
Start Date Type: None
Primary Completion Date: 2015-10
Primary Completion Date Type: ACTUAL
Completion Date: 2015-10
Completion Date Type: ACTUAL
First Submit Date: 2014-09-29
First Submit QC Date: September 29 2014
Study First Post Date: 2014-10-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-02-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-12-23
Last Update Post Date: 2017-02-16
Last Update Post Date Type: ACTUAL